- St. Jude (NYSE:STJ) released second quarter earnings this morning, and issued lower sales guidance for its Cardiac Rhythm Segment (CRM), which represents over 50% of … Continue Reading
Read now- AMAG Pharmaceuticals (NASDAQ:AMAG) announced this morning positive Phase III results for Feraheme as a treatment for anemia in the broad iron deficient population. Currently, this … Continue Reading
Read now- In expectation of a takeover, Allos Therapeutics (NASDAQ:ALTH) is up 14% this morning off of yesterday afternoon’s plummet, but has yet to regain completely. Shareholders … Continue Reading
Read now- Stemcells, Inc (NASDAQ:STEM) is up 27% premarket on preclinical data showing improved memory and synaptic function in two animal models after transplantation of the company’s … Continue Reading
Read now- On July 9, QLT, Inc. (NASDAQ:QLTI) announced major changes to its business plan including the reduction of 146 employees, the planned departure of CEO Robert … Continue Reading
Read now- Johnson and Johnson (NYSE:JNJ) reported Q2 earnings this morning that were largely in-line with forecasts, although global sales fell short of expectations slightly at $16.48B. … Continue Reading
Read now- After reporting positive preliminary results for its lupus candidate, blisibimod, at the end of June, including a statistically significant improvement at week 20 vs. placebo … Continue Reading
Read now